Neurozientziak
Saila
![Foto de Neurozientziak](/img/noimage.png)
![Foto de Parc Sanitari Sant Joan de Déu](/img/noimage_org.png)
Parc Sanitari Sant Joan de Déu
Sant Boi de Llobregat, EspañaParc Sanitari Sant Joan de Déu-ko ikertzaileekin lankidetzan egindako argitalpenak (11)
2024
-
Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies
Schizophrenia Bulletin, Vol. 50, Núm. 4, pp. 771-783
-
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study
European Neuropsychopharmacology, Vol. 85, pp. 66-77
-
Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic – A prospective cohort study using web-based surveys.
Psychiatry Research, Vol. 334
2023
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
2022
-
Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic
Journal of Psychiatric Research, Vol. 149, pp. 10-17
-
Mental impact of Covid-19 among Spanish healthcare workers. A large longitudinal survey
Epidemiology and Psychiatric Sciences, Vol. 31
2021
-
Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis
Schizophrenia Research, Vol. 236, pp. 19-28
-
Mental health impact of the first wave of COVID-19 pandemic on Spanish healthcare workers: A large cross-sectional survey
Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 2, pp. 90-105
-
Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder
Revista de Psiquiatria y Salud Mental
-
Thirty-day suicidal thoughts and behaviors among hospital workers during the first wave of the Spain COVID-19 outbreak
Depression and Anxiety, Vol. 38, Núm. 5, pp. 528-544
2020
-
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort
Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552